Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Oliver Higuera Gómez"'
Autor:
Benjamín Folgueira Hernández Folgueira Hernández, Elena María Brozos Vázquez, Juan Carlos Cámara Vicario, Luis Olay Gayoso, María Belén González Gragera, Oliver Higuera Gómez, Patrícia Ramirez Daffos, Hugo Arasanz Arasanz Esteban, Enrique García Gen
Publikováno v:
Revista de la Sociedad Española del Dolor.
Autor:
Carmen Beato Zambrano, Antonio Javier Jiménez López, Anna Librán Oriol, Gala Serrano Bermúdez, Oliver Higuera Gómez, Pilar Torres, Jose L. Perez, Almudena Sanz Yagüe, Alfredo Paredes Lario, Rodolfo Chicas Sett, Manuel Cobo Dols, Ibone Huerta González, María Isabel Blancas López-Barajas, Alexandra Giraldo Marín, Pedro Sánchez Mauriño, Luis Cabezón Gutiérrez, Diana Moreno Muñoz, Begoña Soler López, Ignacio Delgado Mingorance, Francisco Javier García Navalón
Publikováno v:
BMJ Supportive & Palliative Care
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
ObjectivesOpioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as efficacy and safety of naloxegol, in patients with cancer with OIC.MethodsAn observat
Autor:
Rodolfo Chicas-Sett, Gala Serrano Bermúdez, Anna Librán Oriol, Francisco Javier García Navalón, Oliver Higuera Gómez, Manuel Cobo Dols, Pedro Sánchez Mauriño, Alexandra Giraldo Marín, Pilar Torres, Ibone Huerta González, Almudena Sanz-Yagüe, Ignacio Delgado Mingorance, Jose L. Perez, Luis Cabezón-Gutiérrez, María Isabel Blancas López-Barajas, Carmen Beato Zambrano, Diana Moreno Muñoz, Begoña Soler López, Alfredo Paredes Lario
Publikováno v:
BMJ Supportive & Palliative Care. :bmjspcare-2020
ObjectivesNaloxegol is a peripherally acting µ-opioid receptor antagonist (PAMORA) for treatment of opioid-induced constipation (OIC). The main objective was to analyse the long-term efficacy, quality of life (QOL) and safety of naloxegol in patient
Autor:
Virginia Martínez, Angela Del Pozo Mate, Prudencio Diaz Agero, Patricia Cruz, Inmaculada Ibáñez de Cáceres, Kristina Ibáñez, Julián Nevado Blanco, Javier de Castro, Oliver Higuera Gómez, Olga Pernía, Rocio Rosas Alonso, Carlos Rodríguez Antolín, Elena Vallespin Garcia
Publikováno v:
Journal of Clinical Oncology. 34:e20068-e20068
e20068Background: This is an innovative project that aims to implement NGS to detect new genetic alterations in the early stages of NSCLC and their potential role as biomarkers of the tumoral evolu...
Autor:
Nuria Rodríguez, Virginia Martínez, Jaime Feliu, Jose Reyes, Ana Custodio, Ismael Ghanem, Jose Castell, Oliver Higuera Gómez, Alberto Mata, Laura G. Pastrián
Publikováno v:
Journal of Clinical Oncology. 33:780-780
780 Background: Approximately 10% of patients (p) with rectal cancer have synchronic liver-only metastasis (RCSLM). Although local and systemic therapies are required for this setting, there is not a well defined sequence of treatments. We analyze bo
Autor:
Lucía Sáenz Cuervo-Arango, Laia Vilà, Silverio Ros Martínez, Amaia Moreno Paul, Diego Pérez Parente, Pedro Ruiz Gracia, Oliver Higuera Gómez, Ana Laura Ortega Granados
Publikováno v:
BASE-Bielefeld Academic Search Engine
Cancer Management and Research
Cancer Management and Research
Purpose Identifying patient characteristics that define a worse disease prognosis or "high tumor burden" (HTB) status is essential for clinical decision-making and treatment selection in metastatic non-small cell lung cancer (mNSCLC). We aimed to def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327ca0eb7c8e6e3b9f35ef3e380c0dc4
https://www.dovepress.com/high-tumor-burden-in-metastatic-non-small-cell-lung-cancer-defining-th-peer-reviewed-fulltext-article-CMAR
https://www.dovepress.com/high-tumor-burden-in-metastatic-non-small-cell-lung-cancer-defining-th-peer-reviewed-fulltext-article-CMAR